Detalhe da pesquisa
1.
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells.
Cancer Immunol Immunother
; 73(3): 45, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349430
2.
Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising virus-specific and anti-myeloma T-cell responses.
Haematologica
; 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385273
3.
A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products.
Cytotherapy
; 26(4): 318-324, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340107
4.
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma.
Br J Haematol
; 195(3): 405-412, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34500492
5.
Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk.
PLoS Genet
; 14(2): e1007111, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29389935
6.
B cell maturation antigen-specific chimeric antigen receptor T cells for relapsed or refractory multiple myeloma: A meta-analysis.
Eur J Haematol
; 104(4): 318-327, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31883150
7.
Biomarkers for checkpoint inhibition in hematologic malignancies.
Semin Cancer Biol
; 52(Pt 2): 198-206, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29775689
8.
The role of surface molecule CD229 in Multiple Myeloma.
Clin Immunol
; 204: 69-73, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30326256
9.
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.
Cancer Immunol Immunother
; 68(5): 799-812, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30770959
10.
Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy.
Blood
; 140(2): 152-156, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35537186
11.
Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells.
Haematologica
; 109(2): 682-688, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37675514
12.
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.
J Natl Compr Canc Netw
; 16(1): 11-20, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29295877
13.
Pooled study of occupational exposure to aromatic hydrocarbon solvents and risk of multiple myeloma.
Occup Environ Med
; 75(11): 798-806, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30121582
14.
An Anti-Programmed Death-1 Antibody (αPD-1) Fusion Protein That Self-Assembles into a Multivalent and Functional αPD-1 Nanoparticle.
Mol Pharm
; 14(5): 1494-1500, 2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28343398
15.
Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(2): 230-269, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28188192
16.
Current Strategies for the Immunotherapy of Multiple Myeloma.
Oncology (Williston Park)
; 31(1): 55-63, 2017 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28090624
17.
Chimeric Antigen Receptor (CAR) therapy for multiple myeloma.
Br J Haematol
; 172(5): 685-98, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26791002
18.
Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium.
Br J Haematol
; 175(1): 87-101, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27330041
19.
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.
J Natl Compr Canc Netw
; 14(4): 389-400, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27059188
20.
Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension.
BMC Pulm Med
; 16(1): 145, 2016 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27835955